[1] BRAUN MM,OVERBEEK-WAGER EA,GRUMBO RJ.Diagnosis and management of endometrial cancer[J].Am Fam Physician,2016,93(6):468-474.
[2] LIU Y,WANG X,WAN L,et al.TIPE2 inhibits the migration and invasion of endometrial cells by targeting β-catenin to reverse epithelial-mesenchymal transition[J].Hum Reprod,2020,35(6):1377-1390.
[3] KASOHA M,DERNEKTSI C,SEIBOLD A,et al.Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer[J].J Cancer Res Clin Oncol,2020,146(2):315-327.
[4] SEPULT C,BELLEFROID M,ROCKS N,et al.ADAM10 mediates malignant pleural mesothelioma invasiveness[J].Oncogene,2019,38(18):3521-3534.
[5] STASIKOWSKA-KANICKA O,WAGROWSKA-DANILEWICZ M,KULICKA P,et al.Overexpression of ADAM10 in oral squamous cell carcinoma with metastases[J].Pol J Pathol,2018,69(1):67-72.
[6] LIU F,ZHUANG L,WU R,et al.miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10[J].J BUON,2019,24(5):1905-1912.
[7] SUN L,CHEN B,WU J,et al.Epigenetic regulation of a disintegrin and metalloproteinase (ADAM) transcription in colorectal cancer cells:Involvement of β-Catenin,BRG1,and KDM4[J].Front Cell Dev Biol,2020,8:581692.
[8] YORIKI K,MORI T,KOKABU T,et al.Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer[J].Sci Rep,2019,9(1):6697.
[9] CHIU H,LI C,YIANG G,et al.Epithelial to mesenchymal transition and cell biology of molecular regulation in endometrial carcinogenesis[J].J Clin Med, 2019,8(4):439.
[10] NOWAKOWSKI R,GRABAREK B,BURNAT-OLECH A,et al.Variances in the expression profile of the EMT-related genes in endometrial cancer lines in vitro study[J].Curr Pharm Biotechnol,2022,23(4):594-608.
[11] CAI L,HU C,YU S,et al.Identification of EMT-related gene signatures to predict the prognosis of patients with endometrial cancer[J].Front Genet,2020,11:582274.
[12] CAMODECA C,CUFFARO D,NUTI E,et al.ADAM metalloproteinases as potential drug targets[J].Curr Med Chem,2019,26(15):2661-2689.
[13] SMITH TM,THARAKAN A,MARTIN RK,et al.Targeting ADAM10 in cancer and autoimmunity[J].Front Immunol,2020,11:499.
[14] ROSSELLO A,STEINLE A,POGGI A,et al.Editorial:ADAM10 in cancer immunology and autoimmunity:more than a simple biochemical scissor[J].Front Immunol,2020,11:1483.
[15] GUERRA E,TREROTOLA M,RELLI V,et al.Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer[J].Neoplasia,2021,23(9):898-911.
[16] MUELLER AC,PIPER M,GOODSPEED A,et al.Induction of ADAM10 by radiation therapy drives fibrosis,resistance,and epithelial-to-mesenchyal transition in pancreatic cancer[J].Cancer Res,2021,81(12):3255-3269.
[17] 李根林,刘杰,谢晶,等.miR-122-5p靶向ADAM10调控Notch信号通路对人卵巢癌细胞SKOV-3的上皮-间质转化的抑制作用[J].安徽医科大学学报, 2021,56(1):54-59.
LI GL,LIU J,XIE J,et al.Inhibition effect of miR-122-5p targeted ADAM10 regulates Notch signaling pathway on epithelial-mesenchymal transformation in human ovarian cancer SKOV-3 cells[J].Acta Universitatis Medicinalis Anhui, 2021,56(1):54-59.
[18] MENG H,HUANG Q,ZHANG X,et al.MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10[J]. Onco Targets Ther,2019,12:3829-3838.
[19] CHERIYAMUNDATH S,BENEN-ZE' EV A.Wnt/β-Catenin target genes in colon cancer metastasis:the special case of L1CAM[J].Cancers (Basel),2020,12(11):3444.
[20] MCMELLEN A,WOODRUFF ER,CORR BR,et al.Wnt signaling in gynecologic malignancies[J].Int J Mol Sci,2020,21(12):4272.
[21] CAO J,LIU D,ZHAO S,et al.Estrogen attenuates TGF-β1-induced EMT in intrauterine adhesion by activating Wnt/β-catenin signaling pathway[J].Braz J Med Biol Res,2020,53(8):e9794.
[22] FATIMA I,BARMAN S,RAI R,et al.Targeting Wnt signaling in endometrial cancer[J].Cancers (Basel),2021,13(10):2351.
[23] CHEN P,XING T,WANG Q,et al.MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma[J].Biosci Rep,2019,39(10):BSR20190680.
[24] YUAN Q,YU H,CHEN J,et al.ADAM10 promotes cell growth,migration,and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p[J].Cancer Cell Int,2020,20:99.